| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
AO4 ADHERENCE TO GASTROPROTECTION AND THE RISK OF NSAID-RELATED UPPER GASTROINTESTINAL COMPLICATIONS
|
Van Soest, E
|
|
2007
|
10 |
Supplement 1 |
p. A7-
1 p.
|
article
|
| 2 |
AR3 CAUSES AND EFFECTS OF SCENARIO REJECTION: STATED PREFERENCES FOR RHEUMATOID ARTHRITIS TREATMENTS
|
Ozdemir, S
|
|
2007
|
10 |
Supplement 1 |
p. A1-A2
nvt p.
|
article
|
| 3 |
Assessment of Cardiometabolic Risk Factors in a National Primary Care Electronic Health Record Database
|
Brixner, Diana
|
|
2007
|
10 |
Supplement 1 |
p. S29-S36
8 p.
|
article
|
| 4 |
Assessment of Cardiometabolic Risk Factors in a National Primary Care Electronic Health Record Database
|
Brixner, Diana
|
|
2007
|
10 |
Supplement 1 |
p. S29-S36
|
article
|
| 5 |
A Systematic Review Evaluating Health-Related Quality of Life, Work Impairment, and Health-Care Costs and Utilization in Abnormal Uterine Bleeding
|
Liu, Zhimei
|
|
2007
|
10 |
Supplement 1 |
p. 183-194
12 p.
|
article
|
| 6 |
A Systematic Review Evaluating Health-Related Quality of Life, Work Impairment, and Health-Care Costs and Utilization in Abnormal Uterine Bleeding
|
Liu, Zhimei
|
|
2007
|
10 |
Supplement 1 |
p. 183-194
|
article
|
| 7 |
CASE 3 APPLICATION OF COST-EFFECTIVENESS ANALYSIS TO EVALUATE THE PROPOSED FORMULARY STATUS OF A NOVEL ANTIDIABETIC DRUG IN A U.S. COMMERCIAL HEALTH PLAN
|
Watkins, J
|
|
2007
|
10 |
Supplement 1 |
p. A198-
1 p.
|
article
|
| 8 |
CASE 6 INCORPORATION OF COST EFFECTIVENESS FOR FORMULARY ADDITIONS AT A CANCER CENTER
|
Curry, E
|
|
2007
|
10 |
Supplement 1 |
p. A199-A200
nvt p.
|
article
|
| 9 |
CASE3 REVIEWING THE REIMBURSEMENT STATUS OF DRUGS AGAINST ASTHMA, COPD AND COUGHS
|
Hugosson, H
|
|
2007
|
10 |
Supplement 1 |
p. A321-
1 p.
|
article
|
| 10 |
CASE 1 REVIEWING THE REIMBURSEMENT STATUS OF PHARMACEUTICALS—EXPERIENCES FROM SWEDEN
|
Engstrom, A
|
|
2007
|
10 |
Supplement 1 |
p. A197-
1 p.
|
article
|
| 11 |
CN2 DEVELOPMENT ANDVALIDATION OF OPTIMALLYWEIGHTED MEASURES OF GLOBAL HEALTH-RELATED QUALITY OF LIFE (QOL) AND UTILITY BASED ON A CANCER-SPECIFIC QOL INSTRUMENT
|
Grimison, PS
|
|
2007
|
10 |
Supplement 1 |
p. A226-A227
nvt p.
|
article
|
| 12 |
CN2 PHARMACOECONOMIC ANALYSIS OF CAPECITABINE IN ADJUVANT TREATMENT OF STAGE III COLON CANCER IN TAIWAN
|
Hsu, TC
|
|
2007
|
10 |
Supplement 1 |
p. A11-A12
nvt p.
|
article
|
| 13 |
Comparison of Persistence Rates with Angiotensin-Converting Enzyme Inhibitors Used in Secondary and Primary Prevention of Cardiovascular Disease
|
Gogovor, Amédé
|
|
2007
|
10 |
Supplement 1 |
p. 431-441
11 p.
|
article
|
| 14 |
Comparison of Persistence Rates with Angiotensin-Converting Enzyme Inhibitors Used in Secondary and Primary Prevention of Cardiovascular Disease
|
Gogovor, Amédé
|
|
2007
|
10 |
Supplement 1 |
p. 431-441
|
article
|
| 15 |
Cost-Benefit Analysis of Preventing Sudden Cardiac Deaths with an Implantable Cardioverter Defibrillator versus Amiodarone
|
Caro, J. Jaime
|
|
2007
|
10 |
Supplement 1 |
p. 13-22
10 p.
|
article
|
| 16 |
Cost-Benefit Analysis of Preventing Sudden Cardiac Deaths with an Implantable Cardioverter Defibrillator versus Amiodarone
|
Caro, J. Jaime
|
|
2007
|
10 |
Supplement 1 |
p. 13-22
|
article
|
| 17 |
Cost-Effectiveness of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting Associated with Highly Emetogenic Chemotherapy
|
Moore, Susan
|
|
2007
|
10 |
Supplement 1 |
p. 23-31
9 p.
|
article
|
| 18 |
Cost-Effectiveness of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting Associated with Highly Emetogenic Chemotherapy
|
Moore, Susan
|
|
2007
|
10 |
Supplement 1 |
p. 23-31
|
article
|
| 19 |
CS1 EPOETIN ALFA AND DARBEPOETIN ALFA DOSING TRENDS AND DRUG COSTS IN ELDERLY PRE-DIALYSIS CHRONIC KIDNEY DISEASE PATIENTS
|
Mody, S
|
|
2007
|
10 |
Supplement 1 |
p. A12-A13
nvt p.
|
article
|
| 20 |
CV1 POST-AMI DRUGTHERAPY PERSISTENCE AND RISK OF REINFARCTION IN A MEDICAID POPULATION
|
Shaya, FT
|
|
2007
|
10 |
Supplement 1 |
p. A221-
1 p.
|
article
|
| 21 |
DB2 COMPARING BRITISH AND GERMAN DIABETES GUIDANCE WITH RESPECT TO LONGTERM OUTCOMES AND ASSOCIATED COSTS: RESULTS FROMTHE EAGLE DIABETES SIMULATION MODEL
|
Mueller, E
|
|
2007
|
10 |
Supplement 1 |
p. A231-A232
nvt p.
|
article
|
| 22 |
DB3 TREATMENT EFFECT ESTIMATION:A COMPARISON BETWEEN RANDOMIZED CONTROLLED TRIALS AND OBSERVATIONAL STUDY WITH THREE DIFFERENT CAUSAL EFFECT METHODS-PROPENSITY SCORE, MARGINAL STRUCTURE MODEL AND DOUBLY ROBUST METHODS
|
Sun, P
|
|
2007
|
10 |
Supplement 1 |
p. A17-
1 p.
|
article
|
| 23 |
Diabetes Cost Model of a Hospital in Thailand
|
Riewpaiboon, Arthorn
|
|
2007
|
10 |
Supplement 1 |
p. 223-230
8 p.
|
article
|
| 24 |
Diabetes Cost Model of a Hospital in Thailand
|
Riewpaiboon, Arthorn
|
|
2007
|
10 |
Supplement 1 |
p. 223-230
|
article
|
| 25 |
Economic Burden of Osteoporosis-Related Fractures in Medicaid
|
Rousculp, Matthew D.
|
|
2007
|
10 |
Supplement 1 |
p. 144-152
9 p.
|
article
|
| 26 |
Economic Burden of Osteoporosis-Related Fractures in Medicaid
|
Rousculp, Matthew D.
|
|
2007
|
10 |
Supplement 1 |
p. 144-152
|
article
|
| 27 |
Economic Evaluation of Palliative Management versus Peritoneal Dialysis and Hemodialysis for End-Stage Renal Disease: Evidence for Coverage Decisions in Thailand
|
Teerawattananon, Yot
|
|
2007
|
10 |
Supplement 1 |
p. 61-72
12 p.
|
article
|
| 28 |
Economic Evaluation of Palliative Management versus Peritoneal Dialysis and Hemodialysis for End-Stage Renal Disease: Evidence for Coverage Decisions in Thailand
|
Teerawattananon, Yot
|
|
2007
|
10 |
Supplement 1 |
p. 61-72
|
article
|
| 29 |
ED1 COST-EFFECTIVENESS OF INSULIN DETEMIR VERSUS NPH FOR TYPE 1 DIABETES PATIENTS IN A GERMAN SETTING. A MODELING EVALUATION BASED UPON RESULTS FROM A META-ANALYSIS
|
Kotchie, R
|
|
2007
|
10 |
Supplement 1 |
p. A222-
1 p.
|
article
|
| 30 |
Effect of Second-Generation Antidepressants on Mania- and Depression-Related Visits in Adults with Bipolar Disorder: A Retrospective Study
|
Fu, Alex Z.
|
|
2007
|
10 |
Supplement 1 |
p. 128-136
9 p.
|
article
|
| 31 |
Effect of Second-Generation Antidepressants on Mania- and Depression-Related Visits in Adults with Bipolar Disorder: A Retrospective Study
|
Fu, Alex Z.
|
|
2007
|
10 |
Supplement 1 |
p. 128-136
|
article
|
| 32 |
MD4 COST-EFFECTIVENESS OF BONE DENSITOMETRY SCREENING COMBINED WITH ALENDRONATE THERAPY FOR THOSE WHO HAVE OSTEOPOROSIS
|
Hiligsmann, M
|
|
2007
|
10 |
Supplement 1 |
p. A236-
1 p.
|
article
|
| 33 |
ND2 MODELING THE COST-EFFECTIVENESS OF A NEW TREATMENT FOR MS (NATALIZUMAB) COMPARED TO CURRENT STANDARD PRACTICE IN SWEDEN
|
Kobelt, G
|
|
2007
|
10 |
Supplement 1 |
p. A239-A240
nvt p.
|
article
|
| 34 |
PAA13 CATEGORIES AND TRANSITION PATTERNS OF GUIDELINE INFORMED CONTROL IN SEVERE OR DIFFICULT-TO-TREAT ASTHMA
|
Campbell, JC
|
|
2007
|
10 |
Supplement 1 |
p. A112-A113
nvt p.
|
article
|
| 35 |
PAA5 CLINICO-ECONOMICAL ANALYSIS OF USING BUDESONID/ FORMOTEROL INHALER FORTREATMENT OF BRONCHIAL ASTHMA
|
Vorobiev, P
|
|
2007
|
10 |
Supplement 1 |
p. A399-
1 p.
|
article
|
| 36 |
PAA15 EFFECT OF IMMUNOTHERAPY ON DRUG USE AND COST IN RAGWEED POLLEN ALLERGIC DISEASE IN LOMBARDIA
|
Ortolani, C
|
|
2007
|
10 |
Supplement 1 |
p. A402-
1 p.
|
article
|
| 37 |
PAA16 PREDICTORS OF THE PRESCRIBING OF ASTHMA PHARMACOTHERAPY IN THE AMBULATORY PATIENT POPULATION OF THE UNITED STATES
|
Navaratnam, P
|
|
2007
|
10 |
Supplement 1 |
p. A113-
1 p.
|
article
|
| 38 |
PAA18 USING CLAIMS DATA TO MODELTHE BUDGETARY IMPACT OF A NEW TREATMENT FOR RHINITIS
|
Pandya, A
|
|
2007
|
10 |
Supplement 1 |
p. A403-
1 p.
|
article
|
| 39 |
PAR11 COST-EFFECTIVENESS OF ADDING LEFLUNOMIDE TO STANDARD DRUG SEQUENCES FOR RHEUMATOID ARTHRITIS PATIENTS IN POLAND
|
Golicki, D
|
|
2007
|
10 |
Supplement 1 |
p. A246-
1 p.
|
article
|
| 40 |
PAR4 ECONOMIC EVALUATION OF TUMOR NECROSIS FACTOR INHIBITORS IN THE TREATMENT OF ANKYLOSING SPONDYLITIS
|
Parekh, HH
|
|
2007
|
10 |
Supplement 1 |
p. A118-
1 p.
|
article
|
| 41 |
PAR28 GEOGRAPHICAL VARIATION OF PHARMACOLOGICAL PRESCRIPTION WITH BAYESIAN HIERARCHICAL MODELS
|
López-Quílez, A
|
|
2007
|
10 |
Supplement 1 |
p. A251-A252
nvt p.
|
article
|
| 42 |
PAR14 UTILIZATION OF CHRONIC ARTHRITIS-RELATED HEALTH CARE SERVICES BY CHILDREN AND ADOLESCENTS IN A MEDICAID POPULATION
|
Khanna, R
|
|
2007
|
10 |
Supplement 1 |
p. A121-
1 p.
|
article
|
| 43 |
PCASE1 APPLICATION OF PHARMACOECONOMICS TO DOD'S ANTILIPIDEMIC-1 UNIFORM FORMULARY DECISION
|
Richerson, M
|
|
2007
|
10 |
Supplement 1 |
p. A200-A201
nvt p.
|
article
|
| 44 |
PCN30 A COST—UTILITY ANALYSIS MODEL FOR THE SECOND LINE TREATMENT OF METASTATIC RENAL CELL CARCINOMA IN MEXICO
|
Contreras-Hernandez, I
|
|
2007
|
10 |
Supplement 1 |
p. A132-A133
nvt p.
|
article
|
| 45 |
PCN57 BASIC ATTITUDE TO USE OF GENERIC ANTI-CANCER DRUGS FOR BREAST CANCER TREATMENT IN JAPAN
|
Salto, S
|
|
2007
|
10 |
Supplement 1 |
p. A340-
1 p.
|
article
|
| 46 |
PCN12 COLORECTAL CANCER: COST-EFFECTIVENESS OF SCREENING AND CHEMOPREVENTION IN AVERAGE RISK MALES
|
Coffindaffer, JW
|
|
2007
|
10 |
Supplement 1 |
p. A126-A127
nvt p.
|
article
|
| 47 |
PCN71 CONJOINT ANALYSIS ATECHNIQUE TO DEVELOP A QUESTIONNAIRE OF TREATMENT PREFERENCES IN PATIENTS WITH LUNG CANCER
|
Perulero, N
|
|
2007
|
10 |
Supplement 1 |
p. A344-A345
nvt p.
|
article
|
| 48 |
PCN16 COST-EFFECTIVENESS ANALYSIS OF ADJUVANT TRASTUZUMAB FOR HER-2 POSITIVE EARLY BREAST CANCER IN TAIWAN
|
Chao, TY
|
|
2007
|
10 |
Supplement 1 |
p. A327-
1 p.
|
article
|
| 49 |
PCN33 COST-MINIMIZATION ANALYSIS OF ONCE-PER-CYCLE FIXED-DOSE ADMINISTRATION OF PEGFILGRASTIM VERSUS DAILY FILGRASTIM FORTHE PROPHYLAXIS OF CHEMOTHERAPY-INDUCED FEBRILE NEUTROPENIA IN BRAZIL
|
Lago, S
|
|
2007
|
10 |
Supplement 1 |
p. A332-
1 p.
|
article
|
| 50 |
PCN43 COST OF INTRAVENOUS ADMINISTRATION OF BISPHOSPHONATES IN PATIENTS WITH METASTATIC BREAST CANCER
|
Lundkvist, J
|
|
2007
|
10 |
Supplement 1 |
p. A335-
1 p.
|
article
|
| 51 |
PCN26 FIRST-, SECOND- AND THIRD-LINE CHEMOTHERAPY FOR NONSMALL CELL LUNG CANCER: PATTERNS OF CARE AND COST
|
Ramsey, SD
|
|
2007
|
10 |
Supplement 1 |
p. A131-
1 p.
|
article
|
| 52 |
PCN44 INTEGRATION OF QUALITY OF LIFE WITH SURVIVAL FOR COMPARATIVE HEALTH OUTCOME ASSESSMENT
|
Wang, JD
|
|
2007
|
10 |
Supplement 1 |
p. A137-
1 p.
|
article
|
| 53 |
PCN74 PSYCHOSOCIAL CONSEQUENCES OF ABNORMAL AND FALSE-POSITIVE RESULTS IN LUNG CANCER SCREENING: ADAPTATION OF A QUESTIONNAIRE
|
Thorsen, H
|
|
2007
|
10 |
Supplement 1 |
p. A345-A346
nvt p.
|
article
|
| 54 |
PCN2 RETROSPECTIVE CHART REVIEW OFTHE MANAGEMENT OF HAND-FOOT SYNDROME IN THE TREATMENT OF COLORECTAL CANCER
|
Ralston, SJ
|
|
2007
|
10 |
Supplement 1 |
p. A322-
1 p.
|
article
|
| 55 |
PCN30 THE ECONOMIC BENEFITS OFTEGAFURWITH URACIL (UFTORAL) IN FIRST- LINE METASTATIC COLORECTAL CANCER
|
Ralston, SJ
|
|
2007
|
10 |
Supplement 1 |
p. A331-
1 p.
|
article
|
| 56 |
PCV71 AN EVALUATION OF STATIN PERFORMANCES BIVARIATE AND TRIVARIATE SELECTION RULE APPROACH
|
Livengood, K
|
|
2007
|
10 |
Supplement 1 |
p. A427-A428
nvt p.
|
article
|
| 57 |
PCV54 ATTAINMENT OF LDL CHOLESTEROL GOALS AMONG HIGH RISK PATIENTS WITH CARDIOVASCULAR DISEASE (CVD): HOW LARGE WAS THE GAP BETWEEN EUROPE & THE UNITED STATES (US) IN 2006?
|
Narayanan, S
|
|
2007
|
10 |
Supplement 1 |
p. A422-
1 p.
|
article
|
| 58 |
PCV47 BURDEN OF ILLNESS AMONG PATIENTS AT HIGH RISK FOR MAJOR CARDIOVASCULAR EVENTS
|
Harley, C
|
|
2007
|
10 |
Supplement 1 |
p. A50-A51
nvt p.
|
article
|
| 59 |
PCV72 CHARACTERIZATION OF HYPERTENSIVE PATIENTS WHO MIGHT BENEFIT FROM A COMBINATION OF TWO DRUGS IN ONE PILL FOR REDUCTION OF CARDIOVASCULAR RISK
|
Sturkenboom, MC
|
|
2007
|
10 |
Supplement 1 |
p. A58-
1 p.
|
article
|
| 60 |
PCV26 COST-EFFECTIVENESS OF HIGH DOSE ATORVASTATIN COMPARED TO STANDARD DOSE PRAVASTATIN IN SECONDARY PREVENTION
|
Borgman, B
|
|
2007
|
10 |
Supplement 1 |
p. A413-
1 p.
|
article
|
| 61 |
PCV9 DIFFERENT REDUCTIONS OF HOSPITALISATIONS FOR CARDIOVASCULAR EVENTS AMONG 92035 USERS OF STATINS IN A REAL LIFE SETTING
|
Heintjes, EM
|
|
2007
|
10 |
Supplement 1 |
p. A407-A408
nvt p.
|
article
|
| 62 |
PCV44 EFFECTS OF MEDICAID ACCESS RESTRICTIONS ON STATIN UTILISATION FOR PATIENTS TREATED BY PHYSICIANS PRACTISING IN POOR AND MINORITY NEIGHBORHOODS
|
Headen, AE
|
|
2007
|
10 |
Supplement 1 |
p. A49-A50
nvt p.
|
article
|
| 63 |
PCV23 HOSPITAL COSTS FORTREATMENT OF ACUTE HEART FAILURE: ECONOMIC ANALYSIS OF THE REVIVE II STUDY
|
De Lissovoy, G
|
|
2007
|
10 |
Supplement 1 |
p. A412-
1 p.
|
article
|
| 64 |
PCV58 HOSPITAL POLICIES FOR TREATMENT OF ACUTE DECOMPENSATED HEART FAILURE
|
Vats, V
|
|
2007
|
10 |
Supplement 1 |
p. A53-A54
nvt p.
|
article
|
| 65 |
PCV29 PHARMACOECONOMIC ANALYSIS OF EXTENDED PROPHYLAXIS BY ENOXAPARIN AFTER HIP JOINT REPLACEMENT
|
Lomakin, A
|
|
2007
|
10 |
Supplement 1 |
p. A45-
1 p.
|
article
|
| 66 |
PCV12 SEASONAL VARIATIONS OF THE OCCURRENCE OF ACUTE MYOCARDIAL INFARCTION IN HUNGARY BETWEEN 2000-2004
|
Kriszbacher, I
|
|
2007
|
10 |
Supplement 1 |
p. A40-
1 p.
|
article
|
| 67 |
PCV40 STUDY OF THE COST OF OUTPATIENT HYPERTENSION THERAPY IN BULGARIA
|
Petrova, GI
|
|
2007
|
10 |
Supplement 1 |
p. A417-A418
nvt p.
|
article
|
| 68 |
PCV57 UTILISATION OF DRUGS FOR TREATMENT OF CARDIOVASCULAR DISEASE WITHIN SLOVAKIA
|
Tesar, T
|
|
2007
|
10 |
Supplement 1 |
p. A423-
1 p.
|
article
|
| 69 |
PDB58 CHANGES IN CONCOMITANT DIABETES THERAPIES ASSOCIATED WITH THE INITIATION OF EXENATIDE IN PATIENTS WITH TYPE 2 DIABETES
|
Misurski, D
|
|
2007
|
10 |
Supplement 1 |
p. A272-
1 p.
|
article
|
| 70 |
PDB43 COMPARATIVE STUDY OF ANNUAL TREATMENT COSTS OF GLARGINE INSULIN AND DETEMIR INSULIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN SPAIN
|
Alvarez Guisasola, F
|
|
2007
|
10 |
Supplement 1 |
p. A267-
1 p.
|
article
|
| 71 |
PDB25 COST-EFFECTIVENESS OF DETEMIR VERSUS NPH FOR TYPE 1 DIABETES PATIENTS TREATED WITH BASAL-BOLUS THERAPY IN A BELGIUM SETTING, A MODELING EVALUATION BASED ON RESULTS FROM A META-ANALYSIS OFTHREE CLINICAL TRIALS
|
Scheijbeler, H
|
|
2007
|
10 |
Supplement 1 |
p. A261-
1 p.
|
article
|
| 72 |
PDB20 COST-EFFECTIVENESS OF INSULIN DETEMIR VERSUS NPH FOR TYPE 1 DIABETES PATIENTS IN AN ITALIAN SETTING. A META-ANALYSIS
|
Aristides, M
|
|
2007
|
10 |
Supplement 1 |
p. A260-
1 p.
|
article
|
| 73 |
PDB26 COSTS AND NEONATAL OUTCOMES AFTER INSULIN ASPART COMPARED WITH HUMAN INSULIN IN PREGNANTWOMEN WITHTYPE 1 DIABETES
|
Lloyd, AC
|
|
2007
|
10 |
Supplement 1 |
p. A262-
1 p.
|
article
|
| 74 |
PDB14 ECONOMIC OUTCOMES ASSOCIATED WITH SWITCHING TO INSULIN PEN THERAPY IN MEDICAID TYPE 2 DIABETES PATIENTS: A RETROSPECTIVE DATABASE ANALYSIS
|
Pawaskar, MD
|
|
2007
|
10 |
Supplement 1 |
p. A63-
1 p.
|
article
|
| 75 |
PDB28 IMPACT OF INITIATING OR CONVERTING TO TREATMENT WITH AN INSULIN ASPART ANALOG PEN ON MEDICATION ADHERENCE IN TYPE 2 DIABETES PATIENTS ON VIAL/SYRINGE INSULIN
|
Balu, S
|
|
2007
|
10 |
Supplement 1 |
p. A68-
1 p.
|
article
|
| 76 |
PDB9 INDIRECT COMPARISON OF ONCE DAILY INSULIN DETEMIR AND GLARGINE IN REDUCING WEIGHT GAIN AND ACHIEVING GLYCEMIC CONTROL, WHEN ADMINISTERED IN ADDITION TO CONVENTIONAL ORAL ANTIDIABETIC THERAPY IN THE TREATMENT OFTYPE 2 DIABETES PATIENTS; A META-ANALYSIS
|
Fakhoury, W
|
|
2007
|
10 |
Supplement 1 |
p. A256-
1 p.
|
article
|
| 77 |
PDB24 PRELIMINARY VALIDATION OF THE COGNITIVE DISTRESS, FATIGUE, HYPERGLYCEMIA AND HYPOGLYCEMIA SUBSCALES OF THE DIABETES SYMPTOM CHECKLIST REVISED (DCSR) FOR USE IN CLINICAL TRIALS INVOLVING PATIENTS WITH TYPE 1 OR TYPE 2 DIABETES
|
Kelly, AA
|
|
2007
|
10 |
Supplement 1 |
p. A66-A67
nvt p.
|
article
|
| 78 |
PDB12 ROSIGLITAZONE IN THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES: IMPLEMENTATION OF BUDGET IMPACT ANALYSIS SOFTWARE
|
Zaniolo, O
|
|
2007
|
10 |
Supplement 1 |
p. A257-
1 p.
|
article
|
| 79 |
PDB40 SIMULATION OF LONG-TERM COSTS OF COMPLICATIONS IN TYPE II DIABETES IN THE UNITED STATES
|
Ward, A
|
|
2007
|
10 |
Supplement 1 |
p. A266-
1 p.
|
article
|
| 80 |
PDB11 THE COST-EFFECTIVENESS OF VACUUM ASSISTED CLOSURE® (V.A.C.) THERAPY FOR THE TREATMENT OF DIABETIC FOOT WOUNDS
|
Flack, SM
|
|
2007
|
10 |
Supplement 1 |
p. A62-
1 p.
|
article
|
| 81 |
PDB19 THE RELATIVE COST EFFECTIVENESS OF INSULIN GLARGINE VERSUS NPH INSULIN USING UK REAL LIFE DATA IN TYPE 1 DIABETES MELLITUS
|
McEwan, P
|
|
2007
|
10 |
Supplement 1 |
p. A65-
1 p.
|
article
|
| 82 |
PDB29 THE RELATIVE COST EFFECTIVENESS OF INSULIN GLARGINE VERSUS NPH INSULIN USING UK REAL LIFE DATA IN TYPE 1 DIABETES MELLITUS ANDTHE COMBINED EFFECT OF HBA1C AND HYPOGLYCAEMIA REDUCTION
|
McEwan, P
|
|
2007
|
10 |
Supplement 1 |
p. A262-A263
nvt p.
|
article
|
| 83 |
PDB76 TREATMENT SATISFACTION IS POSITIVELY ASSOCIATED WITH GLYCEMIC CONTROLAND NEGATIVELY ASSOCIATED WITH PATIENT REPORTED EXPERIENCE OF HYPOGLYCEMIC SYMPTOMS AMONG PATIENTS WITH TYPE-2 DIABETES MELLITUS (T2DM) ON ORAL ANTI-HYPERGLYCEMIC AGENTS (OHA) IN EUROPE
|
Alvarez-Guisasola, F
|
|
2007
|
10 |
Supplement 1 |
p. A278-
1 p.
|
article
|
| 84 |
PEY1 COMPARISON OF TOPICAL CIPROFLOXACIN/DEXAMETHASONE OTIC SUSPENSION VERSUS POLYMYXIN B/NEOMYCIN/HYDROCORTISONE OTIC SUSPENSION FOR THE TREATMENT OF ACUTE OTITIS EXTERNA
|
Rahman, A
|
|
2007
|
10 |
Supplement 1 |
p. A141-
1 p.
|
article
|
| 85 |
PEY4 INCREMENTAL COSTS ASSOCIATED WITH ANTIBIOTICS PRESCRIBED FOR ACUTE OTITIS MEDIA
|
Seal, B
|
|
2007
|
10 |
Supplement 1 |
p. A142-
1 p.
|
article
|
| 86 |
PEY12 METHODOLOGICAL ISSUES ARISING FROM THREE STUDIES WHICH INCLUDED CONJOINT ANALYSIS IN VISUALLY IMPAIRED PEOPLE
|
Aspinall, PA
|
|
2007
|
10 |
Supplement 1 |
p. A350-
1 p.
|
article
|
| 87 |
PGI2 BIOLOGICAL AGENTS FOR THE MANAGEMENT OF CROHN'S DISEASE IN ADULTS:A SYSTEMATIC REVIEW, META-ANALYSIS AND MULTIPLE TREATMENT COMPARISON
|
Hughes, D
|
|
2007
|
10 |
Supplement 1 |
p. A147-
1 p.
|
article
|
| 88 |
PG128 IMPACT OF CERTOLIZUMAB PEGOL ON QUALITY-ADJUSTED LIFE-YEARS IN TWO INDUCTION AND MAINTENANCE TRIALS IN PATIENTS WITH ACTIVE CROHN'S DISEASE
|
Tan, SC
|
|
2007
|
10 |
Supplement 1 |
p. A360-
1 p.
|
article
|
| 89 |
PGI17 SYMPTOMS OF GASTROESOPHAGEAL REFLUX DISEASE, CONCOMITANT DISEASES, HEALTH-RELATED QUALITY OF LIFE AND WORK PRODUCTIVITY:A DATABASE STUDY IN A US COHORT
|
Wahlqvist, P
|
|
2007
|
10 |
Supplement 1 |
p. A152-
1 p.
|
article
|
| 90 |
PG114 THE EPIDEMIOLOGY AND HEALTHMCARE RESOURCE USE IN PATIENTS WITH ULCERATIVE COLITIS:A POPULATION BASED UK STUDY
|
Woehl, A
|
|
2007
|
10 |
Supplement 1 |
p. A355-A356
nvt p.
|
article
|
| 91 |
PHM3 ANEMIA IN LONG-TERM CARE PATIENTS: PREVALENCE AND RELATIONSHIP TO FALLS
|
Philpot, T
|
|
2007
|
10 |
Supplement 1 |
p. A153-
1 p.
|
article
|
| 92 |
PHM10 COST OF TRANSFUSION-DEPENDENT MYELODYSPLASTIC SYNDROMES (MDS) IN GERMANY
|
Kuehne, FC
|
|
2007
|
10 |
Supplement 1 |
p. A282-
1 p.
|
article
|
| 93 |
PHM13 THE EFFECT OF RESTRICTING FERTILITY SERVICES IN GERMANY
|
Dietrich, ES
|
|
2007
|
10 |
Supplement 1 |
p. A283-
1 p.
|
article
|
| 94 |
PHP2 A DETERMINATION OF TOPICS FOR HEALTH TECHNOLOGY ASSESSMENT IN THAILAND
|
Chaikledkaew, U
|
|
2007
|
10 |
Supplement 1 |
p. A361-
1 p.
|
article
|
| 95 |
PHP28 ASSESSING LEVELS OF ASSOCIATION BETWEEN HEALTH CARE EXPENDITURE AND HEALTH CARE INDICATORS IN ECONOMICALLY DEVELOPED COUNTRIES
|
Gani, R
|
|
2007
|
10 |
Supplement 1 |
p. A30-
1 p.
|
article
|
| 96 |
PHP16 ASSESSMENT OF DECISION MAKER NEEDS RELATED TO HEALTH ECONOMIC MODELS AND DATA ANALYSIS TOOLS
|
Olson, BM
|
|
2007
|
10 |
Supplement 1 |
p. A365-
1 p.
|
article
|
| 97 |
PHP42 CORRELATION BETWEEN COLLEGE STUDENT ACTIVITIES AND TWO PRODUCTIVITY MEASUREMENTS
|
Dhing, CW
|
|
2007
|
10 |
Supplement 1 |
p. A34-A35
nvt p.
|
article
|
| 98 |
PHP45 DID FDAMA SECTION 114 LEAD TO A DECLINE OF ECONOMIC-CONTENT DRUG ADVERTISING IN MEDICAL JOURNALS?
|
Palmer, JA
|
|
2007
|
10 |
Supplement 1 |
p. A35-A36
nvt p.
|
article
|
| 99 |
PHP1 MEDICATION SAFETY IN COMMUNITY PHARMACY: IMPACT OF SOCIOTECHNICAL FACTORS ON DISPENSING ERRORS
|
Parekh, A
|
|
2007
|
10 |
Supplement 1 |
p. A22-
1 p.
|
article
|
| 100 |
PHP14 POLYPHARMACY IN ELDERLY PATIENTS AT THE MEXICAN INSTITUTE OF SOCIAL SECURITY: SATISFACTION AND COSTS
|
Constantino-Casas, P
|
|
2007
|
10 |
Supplement 1 |
p. A26-
1 p.
|
article
|
| 101 |
PHP26 THE EFFECT OF INJURY SEVERITYANDTRAUMA CENTER DESIGNATION ON INPATIENT COSTS AND OUTCOMES IN HOSPITAL ADMISSIONS FORTRAUMATIC INJURY INTHE UNITED STATES
|
Davis, KL
|
|
2007
|
10 |
Supplement 1 |
p. A368-
1 p.
|
article
|
| 102 |
PHP11 THE VOLUNTARY INCENTIVE STRUCTURE OF PEDIATRIC EXCLUSIVITY AND ITS IMPACTS ON PHARMACEUTICAL INDUSTRY BEHAVIOR AND GENERIC DRUG ENTRIES
|
Rhee, J
|
|
2007
|
10 |
Supplement 1 |
p. A25-
1 p.
|
article
|
| 103 |
PIH1 ASSOCIATION BETWEEN CENTRAL PRECOCIOUS PUBERTY AND COMORBID MEDICAL ILLNESS: LARGE-SCALE RETROSPECTIVE CLAIMS ANALYSIS OF FLORIDA MEDICAID-ENROLLED CHILDREN
|
Hankin, C
|
|
2007
|
10 |
Supplement 1 |
p. A373-
1 p.
|
article
|
| 104 |
PIH4 DRUG COSTS AT THE END OF LIFE
|
Reymen, J
|
|
2007
|
10 |
Supplement 1 |
p. A374-
1 p.
|
article
|
| 105 |
PIH8 MEDICARE PART D AND STATE-LEVEL VARIATIONS IN MEDICARE ADVANTAGE PARTICIPATION
|
Shih, YCT
|
|
2007
|
10 |
Supplement 1 |
p. A157-A158
nvt p.
|
article
|
| 106 |
PIH11 QUALITY-OF-LIFE WEIGHTS FOR THE U.S. POPULATION: SELF-REPORTED HEALTH STATUS AND PRIORITY HEALTH CONDITIONS, BY DEMOGRAPHIC CHARACTERISTICS
|
Nyman, JA
|
|
2007
|
10 |
Supplement 1 |
p. A158-A159
nvt p.
|
article
|
| 107 |
PIH19 TEMPORAL PATTERNS IN HEALTH RELATED QUALITY OF LIFE IN HOSPITALIZED PATIENTS IN THE UNITED KINGDOM
|
Wechowski, JG
|
|
2007
|
10 |
Supplement 1 |
p. A378-A379
nvt p.
|
article
|
| 108 |
PIN20 COST EFFECTIVENESS ANALYSIS OF BRIVUDINE COMPARED WITH ACICLOVIR FORTHETREATMENT OF HERPES ZOSTER IN SPAIN
|
Darba, J
|
|
2007
|
10 |
Supplement 1 |
p. A441-A442
nvt p.
|
article
|
| 109 |
PIN23 COST-EFFECTIVENESS ANALYSIS OF THE IMPLEMENTATION OF A QUADRIVALENT (6,1 1, 16,18 TYPES) HUMAN PAPILLOMAVIRUS VACCINE TO THE EXISTING BELGIAN CERVICAL CANCER SCREENING PROGRAMME
|
Annemans, L
|
|
2007
|
10 |
Supplement 1 |
p. A442-A443
nvt p.
|
article
|
| 110 |
PIN13 COST-EFFECTIVENESS OF LINEZOLID IN GRAM-POSITIVE INFECTIONS: CONSISTENCY OF ECONOMIC ADVANTAGE FROM MULTIPLE HEALTH CARE SYSTEMS
|
Duttagupta, S
|
|
2007
|
10 |
Supplement 1 |
p. A163-
1 p.
|
article
|
| 111 |
PIN37 COST-UTILITY OF ALFAPEGINTERFERON-2A (40 KD) IN CO-INFECTED PATIENTS IN THE PRIVATE HEALTH CARE SYSTEM IN BRAZIL
|
Crespo, D
|
|
2007
|
10 |
Supplement 1 |
p. A447-
1 p.
|
article
|
| 112 |
PIN6 EPIDEMIOLOGIC AND ECONOMIC IMPACT OF ROUTINE VACCINATION OF INFANTS AGAINST ROTAVIRUS GASTROENTERITIS IN GERMANY: A PRELIMINARY ANALYSIS
|
Hammerschmidt, T
|
|
2007
|
10 |
Supplement 1 |
p. A437-
1 p.
|
article
|
| 113 |
PIN30 SMOKING STATUS AND PNEUMONIA IMMUNIZATION: FINDINGS FROM THE 2005 BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM (BRFSS) DATA
|
Parekh, RH
|
|
2007
|
10 |
Supplement 1 |
p. A168-
1 p.
|
article
|
| 114 |
PIN27 USING DECISION SIMULATION MODEL TO EVALUATE THE COST EFFECTIVENESS OF ENTECAVIR COMPARED TO ADEFOVIR THERAPY IN LAMIVUDINE REFRACTORY CHRONIC HEPATITIS B (CHB) PATIENTS:ANALYSES FROM A US PAYER PERSPECTIVE
|
Yuan, Y
|
|
2007
|
10 |
Supplement 1 |
p. A167-A168
nvt p.
|
article
|
| 115 |
PMC25 A MEDIAN MODEL OF US EQ-5D HEALTH STATE PREFERENCES
|
Shaw, JW
|
|
2007
|
10 |
Supplement 1 |
p. A191-
1 p.
|
article
|
| 116 |
PMC8 CREATING KNOWLEDGE ABOUT ADVERSE DRUG REACTIONS:A CRITICAL ANALYSIS OF THE DANISH REPORTING SYSTEM FROM 1968 TO 2005
|
Aagaard, L
|
|
2007
|
10 |
Supplement 1 |
p. A186-
1 p.
|
article
|
| 117 |
PMC21 INFLUENCE OF “SOCIAL” AND “SCHOOL” LIFE DIMENSIONS ON CHILDREN'S QUALITY OF LIFE ASSESSED WITH EQ-5D (CHILD)
|
Matteucci, MC
|
|
2007
|
10 |
Supplement 1 |
p. A457-
1 p.
|
article
|
| 118 |
PMC4 PROBABILISTIC SENSITIVITY ANALYSES IN HEALTH ECONOMIC MODELING STUDIES: A QUALITY ASSESSMENT
|
Getsios, D
|
|
2007
|
10 |
Supplement 1 |
p. A451-A452
nvt p.
|
article
|
| 119 |
PMC7 THE USE OF DISEASE TRANSMISSION MODELLING IN COST-EFFECTIVENESS ANALYSES: STRENGTHS AND WEAKNESSES
|
Pitman, RJ
|
|
2007
|
10 |
Supplement 1 |
p. A452-A453
nvt p.
|
article
|
| 120 |
PMH5 A COMPARISON OF TREATMENT-EMERGENT DIABETES AMONG ATYPICAL AND TYPICAL ANTIPSYCHOTIC USERS: USING A BIVARIATE PROBIT MODEL
|
Stafkey-Mailey, DR
|
|
2007
|
10 |
Supplement 1 |
p. A72-A73
nvt p.
|
article
|
| 121 |
PMH4 EFFICACY OF ANTIPSYCHOTICS IN NEGATIVE SYMPTOMS OF SCHIZOPHRENIAS META-ANALYSIS OF RANDOMIZED CLINICAL TRIALS
|
Darba, J
|
|
2007
|
10 |
Supplement 1 |
p. A288-
1 p.
|
article
|
| 122 |
PMH42 IMPACT OF ALTERNATIVE CENSORING SPECIFICATIONS ON TIME-TO-EVENT ANALYSES COMPARING ALTERNATIVE MEDICATIONS
|
McCombs, JS
|
|
2007
|
10 |
Supplement 1 |
p. A84-
1 p.
|
article
|
| 123 |
PMH59 LINGUISTIC VALIDATION OF THE HADS FOR USE IN INTERNATIONAL STUDIES
|
Grataloup, G
|
|
2007
|
10 |
Supplement 1 |
p. A306-
1 p.
|
article
|
| 124 |
PMH24 36-MONTH COST-UTILITY ANALYSIS OF ANTIPSYCHOTIC TREATMENTS IN PATIENTS WITH SCHIZOPHRENIA IN THE PAN-EUROPEAN SOHO (SCHIZOPHRENIA OUTPATIENT HEALTH OUTCOMES) STUDY
|
Windmeijer, F
|
|
2007
|
10 |
Supplement 1 |
p. A78-A79
nvt p.
|
article
|
| 125 |
PMH9 NET BENEFIT ANALYSIS OF DIVALPROEX SODIUM EXTENDED-RELEASE COMPARED TO VALPROIC ACID IN THE TREATMENT OF BIPOLAR DISORDER
|
Gupta, SR
|
|
2007
|
10 |
Supplement 1 |
p. A73-A74
nvt p.
|
article
|
| 126 |
PMH18 PRESCRIBING PATTERN OF CITALOPRAM AND ESCITALOPRAM IN THE CANTON OF GENEVA A POTENTIAL FOR MAJOR SAVINGS
|
Girardin, F
|
|
2007
|
10 |
Supplement 1 |
p. A292-A293
nvt p.
|
article
|
| 127 |
PMH35 SERTINDOLE IN THE TREATMENT OF SCHIZOPHRENIA IN POLAND: A COST ANALYSIS
|
Hansen, K
|
|
2007
|
10 |
Supplement 1 |
p. A298-
1 p.
|
article
|
| 128 |
PMH49 SF-36 AND EQ-5D QUALITY OF LIFE INSTRUMENTS IN MAJOR DEPRESSIVE DISORDER PATIENTS: COMPARISONS OF TWO DIFFERENT TREATMENT OPTIONS
|
Ergun, H
|
|
2007
|
10 |
Supplement 1 |
p. A303-
1 p.
|
article
|
| 129 |
PMH21 THE COST-EFFECTIVENESS OF RISPERIDONE LONG-ACTING INJECTABLE IN SWEDEN
|
Damen, J
|
|
2007
|
10 |
Supplement 1 |
p. A293-A294
nvt p.
|
article
|
| 130 |
PMS1 DIRECT HEALTH COSTS OF TREATING PATIENTS WITH FIBROMYALGIA IN PRIMARY CARE SETTINGS (PCS) UNDER ROUTINE MEDICAL PRACTICE:A COST OF ILLNESS STUDY USING A CLAIM DATABASE IN SPAIN
|
Sicras, A
|
|
2007
|
10 |
Supplement 1 |
p. A461-
1 p.
|
article
|
| 131 |
PND11 COMPARATIVE ANALYSIS OF MULTIPLE SCLEROSIS COST-EFFECTIVENESS MODELS: FOCUS ON THE UNITED STATES MANAGED CARE PERSPECTIVE
|
Papshev, D
|
|
2007
|
10 |
Supplement 1 |
p. A383-
1 p.
|
article
|
| 132 |
PND28 COMPARISON OF FOUR PREFERENCE-BASED SF-36/SF-I2 ALGORITHMS TO EVALUATE THE COST-EFFECTIVENESS OF TREATMENT FOR PRIMARY INSOMNIA WITH ESZOPICLONE
|
Snedecor, SJ
|
|
2007
|
10 |
Supplement 1 |
p. A389-
1 p.
|
article
|
| 133 |
PND14 COST-EFFECTIVENESS OF PREGABALIN ADD-ON MEDICATION IN PATIENTS WITH REFRACTORY PARTIAL EPILEPSY IN FINLAND
|
Linden, K
|
|
2007
|
10 |
Supplement 1 |
p. A384-
1 p.
|
article
|
| 134 |
PND18 DETERMINANTS OF EMERGENCY DEPARTMENT UTILIZATION FOR MIGRAINE CARE
|
Kwong, WJ
|
|
2007
|
10 |
Supplement 1 |
p. A92-
1 p.
|
article
|
| 135 |
PND21 PRODUCT ENHANCEMENTS DECREASE THE INCIDENCE OF INJECTION SITE REACTIONS AND PAIN RESULTING IN IMPROVED ADHERENCE TO THERAPY IN PATIENTS WITH MULTIPLE SCLEROSIS
|
Scanzillo, J
|
|
2007
|
10 |
Supplement 1 |
p. A93-
1 p.
|
article
|
| 136 |
PND4 RESOURCE UTILIZATION PATTERNS WITH TOPIRAMATE FOR MIGRAINE PREVENTION IN THE MANAGED CARE SETTING
|
Yaldo, AZ
|
|
2007
|
10 |
Supplement 1 |
p. A87-
1 p.
|
article
|
| 137 |
PND2 SAFETY AND IMMUNOGENICITY OF REBIF® NEW FORMULATION (RNF) A NEW SUBCUTANEOUS FORMULATION OF INTERFERON BETA-1A 44 MCG THREE TIMES WEEKLY: 1-YEAR RESULTS OF A PHASE IIIB STUDY IN PATIENTS WITH RELAPSING MULTIPLE SCLEROSIS
|
Simsarian, J
|
|
2007
|
10 |
Supplement 1 |
p. A87-
1 p.
|
article
|
| 138 |
POB2 REDUCING GLOBAL CARDIOMETABOLIC RISK IN OVERWEIGHT OR OBESE INDIVIDUALS WITH DYSLIPIDEMIA: PROJECTED BENEFITS OF RIMONABANT IN A REAL WORLD POPULATION
|
Getsios, D
|
|
2007
|
10 |
Supplement 1 |
p. A462-
1 p.
|
article
|
| 139 |
POI4 INPATIENT COSTS AND OUTCOMES ASSOCIATED WITH TRAUMATIC INJURY IN THE UNITED STATES BY INJURY SEVERITY AND TRAUMA CENTER DESIGNATION
|
Candrilli, SD
|
|
2007
|
10 |
Supplement 1 |
p. A97-
1 p.
|
article
|
| 140 |
POS5 LITERATURE REVIEW ON THE COSTS OF NON-COMPLIANCE IN OSTEOPOROSIS
|
Cowell, W
|
|
2007
|
10 |
Supplement 1 |
p. A394-A395
nvt p.
|
article
|
| 141 |
PPN6 A COST MINIMIZATION ANALYSIS OF IV BOLUS VERSUS IV INFUSION DICLOFENAC IN POST-OPERATIVE PAIN
|
Wallerstein, K
|
|
2007
|
10 |
Supplement 1 |
p. A173-
1 p.
|
article
|
| 142 |
PPN7 RESOURCE UTILIZATION DUE TO BREAKTHROUGH PAIN: RESULTS FROM A PROSPECTIVE STUDY ON PATIENTS WITH CHRONIC PAINFUL CONDITIONS
|
Pizzi, LT
|
|
2007
|
10 |
Supplement 1 |
p. A465-A466
nvt p.
|
article
|
| 143 |
Predicting the Prevalence of Cardiometabolic Risk Factors When Clinical Data Are Limited
|
Hollenbeak, Christopher S.
|
|
2007
|
10 |
Supplement 1 |
p. S4-S11
8 p.
|
article
|
| 144 |
Predicting the Prevalence of Cardiometabolic Risk Factors When Clinical Data Are Limited
|
Hollenbeak, Christopher S.
|
|
2007
|
10 |
Supplement 1 |
p. S4-S11
|
article
|
| 145 |
PR3 PATIENTS', PARENTS', AND PHYSICIANS' RISK-BENEFIT TRADE-OFF PREFERENCES FOR CROHN'S DISEASE TREATMENTS
|
Johnson, FR
|
|
2007
|
10 |
Supplement 1 |
p. A225-A226
nvt p.
|
article
|
| 146 |
PRS2 A COST-MINIMIZATION ANALYSIS COMPARING MOXIFLOXACIN VERSUS LEVOFLOXACIN AND CEFTRIAXONE FOR THE TREATMENT OF PATIENTS HOSPITALIZED WITH COMMUNITY-ACQUIRED PNEUMONIA: RESULTS FROM THE MOTIVTRIAL
|
Lloyd, AC
|
|
2007
|
10 |
Supplement 1 |
p. A307-
1 p.
|
article
|
| 147 |
PRS2 CLINICAL OUTCOMES OF PATIENTS HOSPITALIZED WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) EXACERBATIONS IN SINGAPORE
|
Sun, Y
|
|
2007
|
10 |
Supplement 1 |
p. A177-
1 p.
|
article
|
| 148 |
PRS5 COST—EFFECTIVENESS ANALYSIS OF FIRST LINE ANTIBIOTICS FOR THE INPATIENT TREATMENT OF PATIENTS WITH COMMUNITY ACQUIRE PNEUMONIA IN A PUBLIC MEXICAN HOSPITAL
|
Salinas-Escudero, G
|
|
2007
|
10 |
Supplement 1 |
p. A178-
1 p.
|
article
|
| 149 |
PRS16 DEVELOPMENT OF PREFERENCE-BASED EQ-5D UTILITY VALUES FORTHE ST GEORGE'S RESPIRATORY QUESTIONNAIRE-CHRONIC OBSTRUCTIVE PULMONARY DISEASE (SGRQ-COPD)
|
Vardeva, K
|
|
2007
|
10 |
Supplement 1 |
p. A311-
1 p.
|
article
|
| 150 |
PSK10 QUANTITATIVE ASSESSMENT OF PATIENT-DEFINED BENEFIT IN DERMATOLOGY
|
Schaefer, I
|
|
2007
|
10 |
Supplement 1 |
p. A470-
1 p.
|
article
|
| 151 |
PST7 DOES ADMINISTRATION MODE AFFECT ITEM HIERARCHY IN STROKE SPECIFIC QUALITY OF LIFE MEASURE, STROKE IMPACT SCALE?—TELEPHONE AND MAIL ADMINISTRATION METHODS
|
Kwon, S
|
|
2007
|
10 |
Supplement 1 |
p. A183-
1 p.
|
article
|
| 152 |
PUK1 A RETROSPECTIVE COMPARATIVE ANALYSIS OF TREATMENT OUTCOMES OF ALPHA-BLOCKERS IN THE MANAGEMENT OF BENIGN PROSTATIC HYPERPLASIA WITHIN A MANAGED CARE POPULATION
|
Pandya, A
|
|
2007
|
10 |
Supplement 1 |
p. A102-
1 p.
|
article
|
| 153 |
PUK4 HAEMOGLOBIN FLUCTUATIONS IN HAEMODIALYSIS PATIENTS RECEIVING INTRAVENOUS EPOETIN ALFA OR INTRAVENOUS DARBEPOETIN ALFA
|
Walker, R
|
|
2007
|
10 |
Supplement 1 |
p. A103-
1 p.
|
article
|
| 154 |
PUK18 LINGUISTIC VALIDATION OF THE NOCTURIA QUALITY OF LIFE (N-QOL) QUESTIONNAIRE IN 10 LANGUAGES
|
Vats, V
|
|
2007
|
10 |
Supplement 1 |
p. A107-A108
nvt p.
|
article
|
| 155 |
PUK12 THE ECONOMIC BURDEN OF HAEMODIALYSIS IN GREECE DURING 2006
|
Aletras, V
|
|
2007
|
10 |
Supplement 1 |
p. A316-
1 p.
|
article
|
| 156 |
Quality of Life Related to Oral versus Subcutaneous Iron Chelation: A Time Trade-off Study
|
Osborne, Richard H.
|
|
2007
|
10 |
Supplement 1 |
p. 451-456
6 p.
|
article
|
| 157 |
Quality of Life Related to Oral versus Subcutaneous Iron Chelation: A Time Trade-off Study
|
Osborne, Richard H.
|
|
2007
|
10 |
Supplement 1 |
p. 451-456
|
article
|
| 158 |
RS1 A RETROSPECTIVE, OBSERVATIONAL STUDY COMPARING OUTCOMES OF ASTHMATREATMENT WITH FIXED COMBINATIONS OF INHALED CORTICOSTEROID AND LONG-ACTING â2-AGONIST (ICS/LABA) IN REAL-LIFE PRACTICE
|
Thomas, M
|
|
2007
|
10 |
Supplement 1 |
p. A240-A241
nvt p.
|
article
|
| 159 |
Simple Demographic Model to Predict Multiple Cardiometabolic Risk Factors in Two Well-Known Observational Cohorts
|
Scranton, Richard E.
|
|
2007
|
10 |
Supplement 1 |
p. S37-S44
8 p.
|
article
|
| 160 |
Simple Demographic Model to Predict Multiple Cardiometabolic Risk Factors in Two Well-Known Observational Cohorts
|
Scranton, Richard E.
|
|
2007
|
10 |
Supplement 1 |
p. S37-S44
|
article
|
| 161 |
The Cost-Effectiveness of Expanding Newborn Screening for up to 21 Inherited Metabolic Disorders Using Tandem Mass Spectrometry: Results from a Decision-Analytic Model
|
Cipriano, Lauren E.
|
|
2007
|
10 |
Supplement 1 |
p. 83-97
15 p.
|
article
|
| 162 |
The Cost-Effectiveness of Expanding Newborn Screening for up to 21 Inherited Metabolic Disorders Using Tandem Mass Spectrometry: Results from a Decision-Analytic Model
|
Cipriano, Lauren E.
|
|
2007
|
10 |
Supplement 1 |
p. 83-97
|
article
|
| 163 |
The Cost-Effectiveness of Lanthanum Carbonate in the Treatment of Hyperphosphatemia in Patients with End-Stage Renal Disease
|
Brennan, Alan
|
|
2007
|
10 |
Supplement 1 |
p. 32-41
10 p.
|
article
|
| 164 |
The Cost-Effectiveness of Lanthanum Carbonate in the Treatment of Hyperphosphatemia in Patients with End-Stage Renal Disease
|
Brennan, Alan
|
|
2007
|
10 |
Supplement 1 |
p. 32-41
|
article
|
| 165 |
The Cost-Effectiveness of Stem Cell Transplantations from Unrelated Donors in Adult Patients with Acute Leukemia
|
Costa, Vania
|
|
2007
|
10 |
Supplement 1 |
p. 247-255
9 p.
|
article
|
| 166 |
The Cost-Effectiveness of Stem Cell Transplantations from Unrelated Donors in Adult Patients with Acute Leukemia
|
Costa, Vania
|
|
2007
|
10 |
Supplement 1 |
p. 247-255
|
article
|
| 167 |
The Relationship between Influenza Vaccination and Outpatient Visits for Upper Respiratory Infection by the Elderly in Taiwan
|
Tsai, Yi-Wen
|
|
2007
|
10 |
Supplement 1 |
p. 117-127
11 p.
|
article
|
| 168 |
The Relationship between Influenza Vaccination and Outpatient Visits for Upper Respiratory Infection by the Elderly in Taiwan
|
Tsai, Yi-Wen
|
|
2007
|
10 |
Supplement 1 |
p. 117-127
|
article
|
| 169 |
Time from Sexually Transmitted Infection Acquisition to Pelvic Inflammatory Disease Development: Influence on the Cost-Effectiveness of Different Screening Intervals
|
Smith, Kenneth J.
|
|
2007
|
10 |
Supplement 1 |
p. 358-366
9 p.
|
article
|
| 170 |
Time from Sexually Transmitted Infection Acquisition to Pelvic Inflammatory Disease Development: Influence on the Cost-Effectiveness of Different Screening Intervals
|
Smith, Kenneth J.
|
|
2007
|
10 |
Supplement 1 |
p. 358-366
|
article
|
| 171 |
Using EQ-5D to Derive General Population-based Utilities for the Quality of Life Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA)
|
Kołtowska-Häggström, Maria
|
|
2007
|
10 |
Supplement 1 |
p. 73-81
9 p.
|
article
|
| 172 |
Using EQ-5D to Derive General Population-based Utilities for the Quality of Life Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA)
|
Kołtowska-Häggström, Maria
|
|
2007
|
10 |
Supplement 1 |
p. 73-81
|
article
|
| 173 |
Using Real-World Data for Coverage and Payment Decisions: The ISPOR Real-World Data Task Force Report
|
Garrison Jr., Louis P.
|
|
2007
|
10 |
Supplement 1 |
p. 326-335
10 p.
|
article
|
| 174 |
Using Real-World Data for Coverage and Payment Decisions: The ISPOR Real-World Data Task Force Report
|
Garrison, Louis P.
|
|
2007
|
10 |
Supplement 1 |
p. 326-335
|
article
|
Journal description